Pharmacologically active peptides
AssigneeEli Lilly and Company
InventorsPaul D. Gesellchen, Robert T. Shuman
Life of this patent
Estimating the term…
Loading patent…
AssigneeEli Lilly and Company
InventorsPaul D. Gesellchen, Robert T. Shuman
Estimating the term…
Compounds of the formula ##STR1## and pharmaceutically acceptable non-toxic acid addition salts thereof, in which L and D define the chirality; R.sub.1 is hydrogen or C.sub.1 -C.sub.3 primary alkyl; R.sub.2 is C.sub.1 -C.sub.4 primary or secondary alkyl, allyl, cyclopropylmethyl, C.sub.1 -C.sub.2 hydroxyalkyl, or --(CH.sub.2).sub.m --U--CH.sub.3 in which U is --S-- or >S--O and m is 1 or 2; R.sub.3 is hydrogen, C.sub.1 -C.sub.4 primary or secondary alkyl, cyclopropylmethyl, or allyl; R.sub.4 is hydrogen, C.sub.1 -C.sub.5 primary or secondary alkyl, --(CH.sub.2).sub.n --X--(CH.sub.2).sub.p --CH.sub.3 in which X is --O--, --S--, >S--O or ##STR2## n is 1 or 2, and p is 0 or 1, phenyl, or monosubstituted phenyl in which the substituent is halo, hydroxy, C.sub.1 -C.sub.3 alkoxy, nitro, C.sub.1 -C.sub.3 alkyl, or trifluoromethyl; R.sub.5 is hydrogen or C.sub.1 -C.sub.4 primary alkyl; and Z is --CH.sub.2 OR.sub.6, ##STR3## in which R.sub.6 is hydrogen or C.sub.1 -C.sub.3 alkyl and R.sub.7 is C.sub.1 -C.sub.3 alkyl; subject to the proviso that one but not both of R.sub.3 and R.sub.5 is other than hydrogen; are useful analgesic agents.
A compound of the formula ##STR14## and pharmaceutically acceptable non-toxic acid addition salts thereof, in which L and D define the chirality;
Dependencies are inferred from the claim text.